advanced search  
Updated Sep. 1, 2010

 
 
ADVISORY BOARD
Bioethics

Joseph P. DeMarco, PhD
Professor Emeritus of Philosophy, Department of Philosophy, Cleveland State University,
Cleveland, OH

Paul J. Ford, PhD
Associate Staff in Bioethics and Neurology, The Cleveland Clinic Foundation; Assistant Professor, Cleveland Clinic Foundation Lerner College of Medicine of Case Western Reserve University,
Cleveland, OH

 
Community Oncology

Michael J. Fisch, MD, MPH
Medical Director, Clinical Community Oncology Program Research Base, Associate Professor of General Oncology and Palliative Care, University of Texas M.D. Anderson Cancer Center,
Houston, TX

John W. Finnie, MD
Staff Hematologist and Medical Oncologist, David C. Pratt Cancer Center, St. John’s Mercy Medical Center,
St. Louis, MO

 
Hematologic Malignancies

Jennifer R. Brown, MD, PhD
Attending Physician, CLL & Lymphoma Program, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School,
Boston, MA

Richard Stone, MD
Clinical Director of the Adult Acute Leukemia Program, Dana-Farber Cancer Institute; Associate Professor of Medicine, Harvard Medical School,
Boston, MA

 
Oncology Nursing

Betty Ferrell, RN, PhD
Research Scientist, City of Hope National Medical Center,
Duarte, CA

 
Pharmacy

Cindy O’Bryant, PharmD
Associate Professor, Department of Clinical Pharmacy, University of Colorado; Clinical Oncology Specialist, University of Colorado Cancer Center,
Denver, CO

 
Policy and Management

Mary Lou Bowers, MBA,
President and CEO,
Barbara Constable, RN, MBA,
Director,
Rhonda M. Gold, RN, MSN,
Director,
The Pritchard Group,
Rockville, MD

 
Solid Tumors

Bone Metastases

Allan Lipton, MD
Professor of Medicine and Oncology, Milton S. Hershey Medical Center, Penn State University,
Hershey, PA

Breast Cancer

Maura Dickler, MD
Attending Physician, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center; Assistant Professor, Weill Cornell Medical College,
New York, NY

Andrew Seidman, MD
Attending Physician, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center; Associate Professor, Weill Cornell Medical College,
New York, NY

Gastrointestinal Cancer

Edward Chu, MD
Chief, Section of Medical Oncology; Professor of Medicine and Pharmacology; Deputy Director of Clinical Research, Yale Cancer Center, Yale University,
New Haven, CT

Cathy Eng, MD
Associate Professor, Department of Gastrointestinal Medical Oncology, University of Texas, M.D. Anderson Cancer Center,
Houston, TX

Leonard Saltz, MD
Attending Physician, Memorial Sloan-Kettering Cancer Center; Professor of Medicine, Weill Cornell Medical College,
New York, NY

Gastrointestinal Cancer and Sarcoma

Ephraim Casper, MD
Associate Chairman, Regional Network, Department of Medicine, Memorial Sloan Kettering Cancer Center; Professor of Medicine, Weill Cornell Medical College,
New York, NY

Genitourinary Cancer

Ronald Bukowski, MD
Director of Experimental Therapeutics Program, Taussig Cancer Center, Cleveland Clinic Foundation,
Cleveland, OH

Gynecologic Cancer

Maurie Markman, MD
Vice President for Clinical Research, University of Texas M.D. Anderson Cancer Center,
Houston, TX

Lung, and Head and Neck Cancers

Edward S. Kim, MD
Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology, University of Texas, M.D. Anderson Cancer Center,
Houston, TX

Lung Cancer, Emesis

Richard J. Gralla, MD
President, New York Lung Cancer Alliance,
New York NY

 
Symptom Control and Palliative Care

William S. Breitbart, MD
Chief, Psychiatry Service, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center,
New York, NY

Steven D. Passik, PhD
Associate Professor of Psychology in Psychiatry, Weill Cornell Medical College; Associate Attending Psychologist, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center,
New York, NY

Joseph V. Pergolizzi Jr., MD
Adjunct Assistant Professor, Johns Hopkins University School of Medicine,
Baltimore, MD

Russell K. Portenoy, MD
Chairman, Department of Pain Medicine and Palliative Care, Beth Israel Medical Center,
New York, NY

Charles F. von Gunten, MD, PhD
Director of the Center for Palliative Studies, San Diego Hospice and Palliative Care; Medical Director of the Doris A. Howell Service and Associate Clinical Professor of Medicine at the University of California;
San Diego, CA

 
EDUCATIONAL REVIEW
Expanding Treatment Options for Patients With Chronic Myeloid Leukemia
SOLID TUMORS
Vandetanib Active Against Metastatic Thy...  [9/2010] (new)
Experts Debate Use of Maintenance Therap...  [9/2010] (new)
Oncoplasty Interest Grows as Breast Canc...  [9/2010] (new)
more 
HEMATOLOGIC MALIGNANCIES
Biosensor Aims To Improve CML Therapy ...  [9/2010] (new)
In Multiple Myeloma, Maintenance Therapy After Tra...  [8/2010]
Novel Vincristine Formulation Improves Outcomes in...  [8/2010]
more 
SUPPORTIVE CARE
New Guidelines Issued for Clostridium di...  [9/2010] (new)
Investigational Agent Stops Potentially Fatal 5-FU...  [7/2010]
Concern Revving Up Over REMS For ESAs ...  [6/2010]
more 
POLICY AND MANAGEMENT
Controlling Health Care Costs: U.S. Vers...  [9/2010] (new)
Public Protest Leads CMS to Redefine EMR...  [9/2010] (new)
Patients Give High Marks to EHRs ...  [9/2010] (new)
more 

 
 
home  |  about us  |  advertise  |  contact  |  publications
 


Copyright © 2005 - 2010 McMahon Publishing unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.